Needle-Free Drug Delivery Devices Market Set to Reach $5+ Billion by 2035
• The needle-free injection system market is projected to grow at a CAGR of 4% from $606 million in 2024 to 2035, driven by increasing chronic disease prevalence and patient preference for painless administration.
• Microneedle devices market is expected to reach $2.11 billion in 2024 and grow at a faster CAGR of 6.2%, reflecting technological innovations and applications in personalized medicine.
• Key market players include Antares Pharma (acquired by Halozyme), INOVIO Pharmaceuticals, PharmaJet, and 3M, with technological advancements focusing on improved safety, accuracy, and patient compliance.
© Copyright 2025. All Rights Reserved by MedPath